Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.